How much is the price of Denosumab in 2024?

Denosumab (Denosumab) is a drug used to treat bone-related diseases and belongs to the antimetabolite drug class, which is especially suitable for menopausal women and the elderly. The original drug of disosometumab has been launched in China and has been included in medical insurance. Patients can purchase it domestically at a price of more than 1,000 yuan. For specific prices and reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. There are only denosumab original drugs abroad, mainly the Turkish version of the American Amgen original drug. The price is more than 1,000 yuan (the price may fluctuate due to the exchange rate), and the ingredients and efficacy are consistent with the domestic original drug.